Amferia AB
Amferia is a pioneering company specializing in antimicrobial technology, focusing on developing innovative wound care solutions that combat bacteria, including resistant strains, through bio-inspired peptides and platform technologies. Their mission is to revolutionize treatments and address antibiotic resistance with safe, effective, and sustainable antimicrobial products for human and animal health.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Antimicrobial Hydrogel Dressing
A wound dressing that binds and kills 99.9% of bacteria, including resistant strains, providing a safe environment for wound healing.
Veterinary Wound Care Hydrogel
Sterile antimicrobial hydrogel dressing designed for veterinary use, targeting safe healing of animal wounds.
Antimicrobial Hydrogel Dressing
A wound dressing that binds and kills 99.9% of bacteria, including resistant strains, providing a safe environment for wound healing.
Veterinary Wound Care Hydrogel
Sterile antimicrobial hydrogel dressing designed for veterinary use, targeting safe healing of animal wounds.
Services
Engage in discussions for product collaborations, licensing, and distribution.
Receive samples for testing and collaborate on product development.
Engage in discussions for product collaborations, licensing, and distribution.
Receive samples for testing and collaborate on product development.
News & Updates
Amferia was honored to pitch as one of the ‘Next Brilliant in Tech’ at the Brilliant Minds 2019 conference in Stockholm, featuring esteemed guests like Barack Obama.
Amferia’s technology is now available as BactiDefend Dressing within the Snögg Animal Care portfolio, in countries including Denmark, Finland, Germany, Norway, Portugal, Spain, Sweden, and Iceland.
The antimicrobial efficacy and safety of Amferia’s platform have been verified through numerous peer-reviewed studies, demonstrating effectiveness against resistant bacteria and in vivo wound healing.
Amferia’s approach relies less on antibiotics and more on good hygiene, education, and smarter antimicrobial technologies that do not increase resistance risk.
Amferia utilizes bio-inspired antimicrobial peptides that rapidly and selectively kill bacteria, including resistant strains, by disrupting bacterial membranes.
Founded on years of fundamental research at Chalmers University, Amferia developed a new antimicrobial hydrogel platform that effectively kills bacteria, including resistant strains, and is now progressing towards clinical applications.
Amferia was honored to pitch as one of the ‘Next Brilliant in Tech’ at the Brilliant Minds 2019 conference in Stockholm, featuring esteemed guests like Barack Obama.
Amferia’s technology is now available as BactiDefend Dressing within the Snögg Animal Care portfolio, in countries including Denmark, Finland, Germany, Norway, Portugal, Spain, Sweden, and Iceland.
The antimicrobial efficacy and safety of Amferia’s platform have been verified through numerous peer-reviewed studies, demonstrating effectiveness against resistant bacteria and in vivo wound healing.
Amferia’s approach relies less on antibiotics and more on good hygiene, education, and smarter antimicrobial technologies that do not increase resistance risk.
Amferia utilizes bio-inspired antimicrobial peptides that rapidly and selectively kill bacteria, including resistant strains, by disrupting bacterial membranes.
Founded on years of fundamental research at Chalmers University, Amferia developed a new antimicrobial hydrogel platform that effectively kills bacteria, including resistant strains, and is now progressing towards clinical applications.